Xeomin(®) use in patients with systemic immune reactions to other botulinum toxins type A

Eur J Neurol. 2013 Mar;20(3):e45-e46. doi: 10.1111/ene.12076.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Botulinum Toxins, Type A / adverse effects*
  • Botulinum Toxins, Type A / therapeutic use*
  • Drug Hypersensitivity
  • Female
  • Humans
  • Neuromuscular Agents / therapeutic use*
  • Torticollis / drug therapy*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A
  • incobotulinumtoxinA